Victoza® Prefilled Pen for Type 2 Diabetes

This prefilled pen contains liraglutide for adults and children 10 years and older with type 2 diabetes. It helps reduce blood glucose alongside diet and physical activity. You can arrange US delivery from Canada and explore options even without insurance.

What Victoza Is and How It Works

Victoza® is a glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics the body’s incretin hormones, which increase insulin release when glucose rises, reduce glucagon, and slow stomach emptying. Together, these actions can improve fasting and post-meal glucose. This medicine is not insulin and is taken once daily.

CanadianInsulin.com is a prescription referral platform. We verify prescriptions with your prescriber when required, and licensed Canadian pharmacies dispense your order.

This treatment may be used alone or with other antihyperglycemics such as metformin, SGLT2 inhibitors, or basal insulin. It is not for type 1 diabetes or diabetic ketoacidosis. Use only under the guidance of a healthcare professional and follow the official label.

For broader context on disease management, see our overview of Type 2 Diabetes. If you want practical dosing background, review our Dosing Guide.

Who It’s For

This medicine is indicated to improve glycemic control in adults and pediatric patients 10 years and older with type 2 diabetes, as an adjunct to diet and exercise. Patients with a personal or family history of medullary thyroid carcinoma, or with Multiple Endocrine Neoplasia syndrome type 2, should not use it.

If you have a history of pancreatitis, gallbladder disease, severe gastrointestinal disease, or kidney impairment, discuss risks and benefits with your prescriber. If you experience persistent severe abdominal pain, seek medical care promptly.

Some patients may consider the phrase victoza pen for type 2 diabetes during consultations, but your clinician will determine suitability based on your history, goals, and current regimen.

Dosage and Usage

Typical initiation begins at 0.6 mg once daily for at least one week. If tolerated, the dose may be increased to 1.2 mg once daily. If additional glycemic effect is needed, the dose may be raised to 1.8 mg once daily. Take it at the same time each day, with or without food, in the abdomen, thigh, or upper arm. Rotate injection sites to reduce skin reactions.

When adding this treatment to a sulfonylurea or insulin, your prescriber may consider lowering those agents to reduce hypoglycemia risk. Do not adjust your other medications without medical guidance. If you need help with practical technique, see the Injectable Alternatives article for general injection tips.

Each victoza 18mg/3ml pen delivers multiple daily doses using the dose selector. Always confirm the display shows the intended dose before injecting and keep the needle in the skin for the recommended hold time.

Strengths and Forms

The medicine is supplied as a multi-dose, prefilled, disposable pen. Commonly available presentations include a liraglutide 6 mg/ml prefilled pen that contains 3 mL total solution per pen. Pack sizes can vary by pharmacy and market. Availability may change.

Dose options selected on the pen typically include 0.6 mg, 1.2 mg, and 1.8 mg per injection, as directed by your prescriber.

Missed Dose and Timing

If you miss a dose, take it as soon as you remember if it is the same day. If you do not take it that day, skip the missed dose and resume your regular schedule the next day. Do not take extra doses to make up for a missed dose. If several days are missed, refer to the official label or contact your prescriber for guidance before resuming.

Storage and Travel Basics

Unopened pens should be kept refrigerated and protected from light. Do not freeze. If a pen has been frozen, do not use it. After first use, the pen can be kept at room temperature as directed by the label for the in-use period. Keep the cap on when not in use and store out of reach of children.

For travel, carry your pen and supplies in a cooler bag if needed and avoid leaving them in a parked car. Keep medicines in your carry-on bag with a copy of your prescription and supplies. Pack spare needles, alcohol swabs, and a sharps container or an appropriate travel alternative. If your itinerary crosses time zones, keep the dose once daily at your usual local time; ask your clinician for help planning.

For broader medication context, browse our Diabetes Medications or the class page for GLP 1 Agonists.

Pen Handling and Sharps Disposal

Use a new needle for each injection. Attach the needle straight, perform a flow check per the pen instructions before first use, and confirm the dose window. Insert the needle into the recommended injection site and depress the button fully. Keep the needle in place for the label-specified hold time to ensure a complete dose.

Remove the needle after each injection and dispose of it in an FDA-cleared sharps container or a puncture-resistant alternative permitted in your area. Do not recap used needles. Do not share pens or needles, even with a changing needle, due to the risk of infection transmission.

Benefits

GLP-1 receptor agonists can lower A1C and improve fasting and post-meal glucose. Many patients find once-daily dosing practical. This medicine may reduce appetite, which can contribute to caloric control in some individuals. When used with metformin or SGLT2 inhibitors, it can be part of a comprehensive regimen individualized by your clinician.

Side Effects and Safety

• Nausea or vomiting, usually mild to moderate
• Diarrhea or constipation
• Decreased appetite or indigestion
• Headache or dizziness
• Injection site redness, itching, or pain

Serious risks can include pancreatitis, gallbladder disease, acute kidney injury (often related to fluid loss), and a potential risk of thyroid C-cell tumors. This class has a boxed warning about thyroid C-cell tumors. Seek urgent care for severe or persistent abdominal pain, especially with vomiting. Hypoglycemia can occur when combined with insulin or sulfonylureas. Discuss any history of pancreatitis, gallstones, kidney disease, or thyroid nodules with your prescriber.

For background on indications and safety, see this brief Uses explainer.

Drug Interactions and Cautions

This treatment may slow gastric emptying and can affect the absorption rate of some oral medicines. Caution is advised with drugs that require rapid gastrointestinal absorption or have a narrow therapeutic index; consult your pharmacist for timing strategies. Using it with insulin or sulfonylureas can increase hypoglycemia risk; your clinician may adjust those agents. Dehydration from vomiting or diarrhea can worsen kidney function; maintain hydration and seek care if symptoms persist.

What to Expect Over Time

Many patients notice gastrointestinal symptoms at the start that tend to lessen as the body adapts. Consistent daily use, steady meal patterns, and hydration can help tolerance. Monitor your glucose as directed so your care team can evaluate response and adjust your regimen. Weight changes may occur, and overall results can vary by individual factors and adherence.

If you are considering weekly GLP-1 options, read our brief comparison Vs Ozempic.

Compare With Alternatives

Weekly GLP-1 options offer different dosing schedules and devices. Many patients discuss semaglutide or dulaglutide with their clinicians.

Consider once-weekly semaglutide in Ozempic Pens or once-weekly dulaglutide in Trulicity Pens. Your prescriber can help determine which class member fits your goals and medical history.

Pricing and Access

We list transparent options so you can compare the victoza pen price against alternatives and pack sizes. Orders are fulfilled by licensed Canadian pharmacies with US shipping from Canada. Payment methods vary by dispensing pharmacy.

Check current rates and availability on the product page. If you are exploring ways to save, see our seasonal Promotions. For a broader view of injectable options, browse the class page noted above.

Availability and Substitutions

Supply can vary by pack size or strength. If an item is unavailable, your prescriber may recommend another GLP-1 receptor agonist or a different class based on your history. Pharmacists will not substitute without your clinician’s authorization.

Patient Suitability and Cost-Saving Tips

This treatment may be appropriate for patients who need additional glycemic control beyond lifestyle changes and first-line therapies. It may not suit those with a history of pancreatitis, gallbladder disease, or certain thyroid tumors. Your clinician will evaluate risks, benefits, and fit with your other medicines.

To manage expenses, consider multi-month fills if approved by your prescriber to reduce per-shipment fees. Set refill reminders so you do not run out unexpectedly. Review your current regimen with your clinician to ensure you are not paying for overlapping therapies. If costs are a concern, your pharmacist can explain pack options and timing that may help reduce waste.

Questions to Ask Your Clinician

• Starting dose and when to increase
• How to manage nausea early on
• When to adjust other diabetes medicines
• What to do after missed doses
• Signs of pancreatitis or gallbladder issues
• Whether weekly GLP-1 options fit your plan

Authoritative Sources

Review official prescribing and safety information from these sources:

• FDA Prescribing Information database for current label access
• DailyMed for the latest Full Prescribing Information
• Health Canada Drug Product Database listing

Ready to proceed? You can order victoza prefilled pen through CanadianInsulin with prompt, express, cold-chain shipping. Temperature-controlled handling when required is used by dispensing pharmacies.

Medical disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice.